Top

Published in:

01-12-2023 | Original Article

Relationships between sclerostin and morphometric vertebral fractures, bone mineral density, and bone microarchitecture in postmenopausal women

Authors: Hanting Liang, Wenting Qi, Fan Yu, Ruizhi Jiajue, Yue Chi, Wei Liu, Ou Wang, Mei Li, Xiaoping Xing, Wei Yu, Yan Jiang, Weibo Xia

Published in: Archives of Osteoporosis | Issue 1/2023

Abstract

Summary

Higher sclerostin levels in postmenopausal women are associated with improved bone microarchitecture, areal and volumetric bone mineral density, and bone strength. However, the serum sclerostin level had no independent associations with the prevalence of morphometric vertebral fractures in this population after multivariable adjustment.

Purpose

We aim to investigate the associations between serum sclerostin levels and morphometric vertebral fractures (VFs) prevalence, bone mineral density (BMD), and bone microarchitecture in postmenopausal women.

Methods

A total of 274 community-dwelling postmenopausal women were randomized enrolled. We collected general information and measured the serum sclerostin level. Morphometric VFs were assessed on the lateral thoracic and lumbar spine X-rays. Areal BMD and calculated trabecular bone score (TBS) were detected by dual-energy X-ray absorptiometry, and volumetric BMD and bone microarchitecture data were acquired from high-resolution peripheral quantitative computed tomography.

Results

The prevalence of morphometric VFs was 18.6% in the cohort, and it was significantly higher in the lowest quartile of the sclerostin group than that in the highest quartile of the sclerostin group (27.9% vs. 11.8%, p<0.05). But the serum sclerostin had no independent association with the prevalence of morphometric VFs after adjusting by age, body mass index, BMD at the lumbar vertebrae 1–4, and fragility fracture history after 50 years old (odds ratio: 0.995, 95% confidence interval: 0.987–1.003, p=0.239). The serum sclerostin level positively correlated with the areal, volumetric BMDs, and TBS. It also had significant positive associations with Tb.BV/TV, Tb.N, Tb.Th, and Ct.Th, and negative associations with Tb.Sp and Tb.1/N.SD.

Conclusion

Chinese postmenopausal women with higher serum sclerostin levels had a lower prevalence of morphometric VFs, higher BMDs, and better bone microarchitecture. Nevertheless, the serum sclerostin level had no independent association with the prevalence of morphometric VFs.

(2021) Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society. Menopause 28:973–997. https://doi.org/10.1097/gme.0000000000001831

Wang L, Yu W, Yin X et al (2021) Prevalence of osteoporosis and fracture in China: the China Osteoporosis Prevalence Study. JAMA Network Open 4:e2121106CrossRefPubMedPubMedCentral

Zeng Q, Li N, Wang Q et al (2019) The prevalence of osteoporosis in China, a nationwide, multicenter DXA survey. J Bone Miner Res 34:1789–1797CrossRefPubMed

Zeytinoglu M, Jain RK, Vokes TJ (2017) Vertebral fracture assessment: enhancing the diagnosis, prevention, and treatment of osteoporosis. Bone 104:54–65CrossRefPubMed

Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761–1767CrossRefPubMed

Schousboe JT (2016) Epidemiology of vertebral fractures. J Clin Densitom 19:8–22CrossRefPubMed

Poole KE, van Bezooijen RL, Loveridge N, Hamersma H, Papapoulos SE, Löwik CW, Reeve J (2005) Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. FASEB J 19:1842–1844CrossRefPubMed

Holdsworth G, Roberts SJ, Ke HZ (2019) Novel actions of sclerostin on bone. J Mol Endocrinol 62:R167–r185CrossRefPubMed

He J, Zhang H, Wang C et al (2014) Associations of serum sclerostin and polymorphisms in the SOST gene with bone mineral density and markers of bone metabolism in postmenopausal Chinese women. J Clin Endocrinol Metab 99:E665–E673CrossRefPubMed

10.

Xu XJ, Shen L, Yang YP, Lu FR, Zhu R, Shuai B, Li CG, Wu MX (2013) Serum sclerostin levels associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis. Chin Med J 126:2480–2484PubMed

11.

Hampson G, Edwards S, Conroy S, Blake GM, Fogelman I, Frost ML (2013) The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women. Bone 56:42–47CrossRefPubMed

12.

Garnero P, Sornay-Rendu E, Munoz F, Borel O, Chapurlat RD (2013) Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study. Osteoporos Int 24:489–494CrossRefPubMed

13.

Sheng Z, Tong D, Ou Y, Zhang H, Zhang Z, Li S, Zhou J, Zhang J, Liao E (2012) Serum sclerostin levels were positively correlated with fat mass and bone mineral density in central south Chinese postmenopausal women. Clin Endocrinol 76:797–801CrossRef

14.

Kalem MN, Kalem Z, Akgun N, Bakırarar B (2017) The relationship between postmenopausal women’s sclerostin levels and their bone density, age, body mass index, hormonal status, and smoking and consumption of coffee and dairy products. Arch Gynecol Obstet 295:785–793CrossRefPubMed

15.

Arasu A, Cawthon PM, Lui LY, Do TP, Arora PS, Cauley JA, Ensrud KE, Cummings SR (2012) Serum sclerostin and risk of hip fracture in older Caucasian women. J Clin Endocrinol Metab 97:2027–2032CrossRefPubMedPubMedCentral

16.

Dovjak P, Dorfer S, Föger-Samwald U, Kudlacek S, Marculescu R, Pietschmann P (2014) Serum levels of sclerostin and dickkopf-1: effects of age, gender and fracture status. Gerontology 60:493–501CrossRefPubMed

17.

Xia W, Liu Q, Lv J et al (2022) Prevalent vertebral fractures among urban-dwelling Chinese postmenopausal women: a population-based, randomized-sampling, cross-sectional study. Arch Osteoporos 17:120CrossRefPubMedPubMedCentral

18.

Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148CrossRefPubMed

19.

Silva BC, Leslie WD, Resch H, Lamy O, Lesnyak O, Binkley N, McCloskey EV, Kanis JA, Bilezikian JP (2014) Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res 29:518–530CrossRefPubMed

20.

Yu F, Xu Y, Hou Y et al (2020) Age-, site-, and sex-specific normative centile curves for HR-pQCT-derived microarchitectural and bone strength parameters in a Chinese mainland population. J Bone Miner Res 35:2159–2170CrossRefPubMed

21.

Szulc P, Bertholon C, Borel O, Marchand F, Chapurlat R (2013) Lower fracture risk in older men with higher sclerostin concentration: a prospective analysis from the MINOS study. J Bone Miner Res 28:855–864CrossRefPubMed

22.

Wanby P, Nobin R, Von SP, Brudin L, Carlsson M (2016) Serum levels of the bone turnover markers dickkopf-1, sclerostin, osteoprotegerin, osteopontin, osteocalcin and 25-hydroxyvitamin D in Swedish geriatric patients aged 75 years or older with a fresh hip fracture and in healthy controls. J Endocrinol Invest 39:855–863CrossRefPubMed

23.

Rodrigues AM, Eusébio M, Rodrigues AB et al (2019) Low serum levels of DKK2 predict incident low-impact fracture in older women. JBMR Plus 3:e10179CrossRefPubMedPubMedCentral

24.

Ardawi MS, Rouzi AA, Al-Sibiani SA, Al-Senani NS, Qari MH, Mousa SA (2012) High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the Center of Excellence for Osteoporosis Research Study. J Bone Miner Res 27:2592–2602CrossRefPubMed

25.

Ardawi MS, Akhbar DH, Alshaikh A, Ahmed MM, Qari MH, Rouzi AA, Ali AY, Abdulrafee AA, Saeda MY (2013) Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes. Bone 56:355–362CrossRefPubMed

26.

Uygur MM, Yazıcı DD, Buğdaycı O, Yavuz DG (2021) Prevalence of vertebral fractures and serum sclerostin levels in acromegaly. Endocrine 73:667–673CrossRefPubMed

27.

Peng J, Dong Z, Hui Z, Aifei W, Lianfu D, Youjia X (2021) Bone Sclerostin and Dickkopf-related protein-1 are positively correlated with bone mineral density, bone microarchitecture, and bone strength in postmenopausal osteoporosis. BMC Musculoskelet Disord 22:480CrossRefPubMedPubMedCentral

28.

Reppe S, Noer A, Grimholt RM et al (2015) Methylation of bone SOST, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women. J Bone Miner Res 30:249–256CrossRefPubMed

29.

Brennan M, Haugh MG, O'Brien FJ, McNamara LM (2014) Estrogen withdrawal from osteoblasts and osteocytes causes increased mineralization and apoptosis. Horm Metab Res 46:537–545CrossRefPubMed

30.

Emerton KB, Hu B, Woo AA, Sinofsky A, Hernandez C, Majeska RJ, Jepsen KJ, Schaffler MB (2010) Osteocyte apoptosis and control of bone resorption following ovariectomy in mice. Bone 46:577–583CrossRefPubMed

31.

Holdsworth G, Greenslade K, Jose J, Stencel Z, Kirby H, Moore A, Ke HZ, Robinson MK (2018) Dampening of the bone formation response following repeat dosing with sclerostin antibody in mice is associated with up-regulation of Wnt antagonists. Bone 107:93–103CrossRefPubMed

32.

Kruck B, Zimmermann EA, Damerow S et al (2018) Sclerostin neutralizing antibody treatment enhances bone formation but does not rescue mechanically induced delayed healing. J Bone Miner Res 33:1686–1697CrossRefPubMed

33.

Fijalkowski I, Geets E, Steenackers E, Van Hoof V, Ramos FJ, Mortier G, Fortuna AM, Van Hul W, Boudin E (2016) A novel domain-specific mutation in a sclerosteosis patient suggests a role of LRP4 as an anchor for sclerostin in human bone. J Bone Miner Res 31:874–881CrossRefPubMed

34.

Thorson S, Prasad T, Sheu Y, Danielson ME, Arasu A, Cummings SR, Cauley JA (2013) Sclerostin and bone strength in women in their 10th decade of life. J Bone Miner Res 28:2008–2016CrossRefPubMed

35.

Szulc P, Boutroy S, Vilayphiou N, Schoppet M, Rauner M, Chapurlat R, Hamann C, Hofbauer LC (2013) Correlates of bone microarchitectural parameters and serum sclerostin levels in men: the STRAMBO study. J Bone Miner Res 28:1760–1770CrossRefPubMed

36.

Lima JG, Nobrega LHC, Lima NN et al (2017) Normal bone density and trabecular bone score, but high serum sclerostin in congenital generalized lipodystrophy. Bone 101:21–25CrossRefPubMedPubMedCentral

37.

Tozzi R, Masi D, Cipriani F et al (2022) Circulating SIRT1 and sclerostin correlates with bone status in young women with different degrees of adiposity. Nutrients 14(5):983

38.

Matsui S, Yasui T, Kasai K, Keyama K, Kato T, Uemura H, Kuwahara A, Matsuzaki T, Irahara M (2016) Increase in circulating sclerostin at the early stage of menopausal transition in Japanese women. Maturitas 83:72–77CrossRefPubMed

39.

Mödder UI, Clowes JA, Hoey K, Peterson JM, McCready L, Oursler MJ, Riggs BL, Khosla S (2011) Regulation of circulating sclerostin levels by sex steroids in women and in men. J Bone Miner Res 26:27–34CrossRefPubMed

Title: Relationships between sclerostin and morphometric vertebral fractures, bone mineral density, and bone microarchitecture in postmenopausal women
Authors: Hanting Liang
Wenting Qi
Fan Yu
Ruizhi Jiajue
Yue Chi
Wei Liu
Ou Wang
Mei Li
Xiaoping Xing
Wei Yu
Yan Jiang
Weibo Xia
Publication date: 01-12-2023
Publisher: Springer London
Published in: Archives of Osteoporosis / Issue 1/2023
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI: https://doi.org/10.1007/s11657-023-01235-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Relationships between sclerostin and morphometric vertebral fractures, bone mineral density, and bone microarchitecture in postmenopausal women

Abstract

Summary

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Summary

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2023

Two-country comparison of the prescription of bone protection medication before and early after hip fracture

Treatment of osteoporosis with denosumab in patients with decreased kidney function

Fracture risk gradient assessed by categories of bone mineral density and trabecular bone score: the Manitoba BMD Registry

Adipopenia is associated with osteoporosis in community-dwelling non-underweight adults independent of sarcopenia

A new digital case-based educational program Orthogeriatrics TeleECHO, a strategy to improve the care of fragility fracture patients

Current approaches to secondary prevention after hip fracture in England and Wales — an analysis of trends between 2016 and 2020 using the National Hip Fracture Database (NHFD)